Dopamine receptor agonist exhibiting selectivity for the D3
values are 0.5, 3.3, 3.9 and 3.9 nM for D3
receptors respectively). Exhibits negligible affinity for D1
receptors. Displays activity in the treatment of Parkinson's disease.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors.
Mierau et al.
The citations listed below are publications that use Tocris products. Selected citations for Pramipexole dihydrochloride include:
Showing Results 1 - 2 of 2